All In Biotech

Drug Trial Radar · NCT01982123

SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy

Pulmonary Functional Imaging for Radiation Treatment Planning

Last checked: Nov 19, 2026Latest source record: Dec 13, 2018 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

12

Actual

Start

Jan 17, 2014

Primary completion

Sep 13, 2017

Study completion Sep 13, 2017

Sponsor

Lead sponsor
University of WashingtonAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Nov 13, 2013

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This pilot clinical trial studies single photon emission computed tomography (SPECT)/computed tomography (CT) in measuring lung function in patients with cancer undergoing radiation therapy. Diagnostic procedures that measure lung function may help doctors find healthy lung tissue and allow them to plan better treatment.

Conditions

  • Lung Carcinoma
  • Malignant Neoplasm

Interventions

  • SPECT/CTDiagnostic test

    Undergo 99mTc-MAA and 99mTc-DTPA SPECT/CT mid-radiation and post-radiation

  • Single Photon Emission Computed TomographyProcedure

    Undergo 99mTc-MAA and 99mTc-DTPA SPECT/CT

  • Technetium Tc-99m Albumin AggregatedRadiation

    Undergo 99mTc-MAA SPECT/CT

  • Technetium Tc-99m DTPADrug

    Undergo 99mTc-DTPA SPECT/CT

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Spatial Stability of Lung Perfusion and Ventilation Over Time, as Assessed Using 99mTc-MAA SPECT/CTTime frame: Baseline to up to 3 months post-treatment

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

    Seattle, Washington

  • ProCure Proton Therapy Center-Seattle

    Seattle, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.